These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19417672

  • 21. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.
    Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ, Robinson BW.
    Thorax; 2007 Jul; 62(7):569-76. PubMed ID: 17356060
    [Abstract] [Full Text] [Related]

  • 22. The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies.
    Galloway ML, Murray D, Moffat DF.
    Histopathology; 2006 May; 48(6):767-9. PubMed ID: 16681698
    [No Abstract] [Full Text] [Related]

  • 23. Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?
    Creaney J, Dick IM, Dare H, Demelker Y, Nowak AK, Musk AW, Robinson BW.
    Lung Cancer; 2013 Apr; 80(1):39-44. PubMed ID: 23357461
    [Abstract] [Full Text] [Related]

  • 24. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
    Creaney J, Robinson BW.
    Hematol Oncol Clin North Am; 2005 Dec; 19(6):1025-40, v. PubMed ID: 16325121
    [Abstract] [Full Text] [Related]

  • 25. Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.
    Grigoriu B, Chahine B, Zerimech F, Grégoire M, Balduyck M, Copin MC, Devos P, Lassalle P, Scherpereel A.
    Clin Biochem; 2009 Jul; 42(10-11):1046-50. PubMed ID: 19302997
    [Abstract] [Full Text] [Related]

  • 26. Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.
    Creaney J, Dick IM, Segal A, Musk AW, Robinson BW.
    Lung Cancer; 2013 Dec; 82(3):491-8. PubMed ID: 24161718
    [Abstract] [Full Text] [Related]

  • 27. Mesothelin-family proteins and diagnosis of mesothelioma.
    Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I.
    Lancet; 2003 Nov 15; 362(9396):1612-6. PubMed ID: 14630441
    [Abstract] [Full Text] [Related]

  • 28. Clinical utility of diagnostic markers for malignant pleural mesothelioma.
    Grigoriu BD, Grigoriu C, Chahine B, Gey T, Scherpereel A.
    Monaldi Arch Chest Dis; 2009 Mar 15; 71(1):31-8. PubMed ID: 19522163
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.
    Canessa PA, Franceschini MC, Ferro P, Battolla E, Dessanti P, Manta C, Sivori M, Pezzi R, Fontana V, Fedeli F, Pistillo MP, Roncella S.
    Cancer Invest; 2013 Jan 15; 31(1):43-50. PubMed ID: 23249166
    [Abstract] [Full Text] [Related]

  • 30. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
    Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano I, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass HI, Carbone M, Yang H.
    Clin Cancer Res; 2016 Jun 15; 22(12):3087-96. PubMed ID: 26733616
    [Abstract] [Full Text] [Related]

  • 31. Biomarkers for malignant pleural mesothelioma: a meta-analysis.
    Gillezeau CN, van Gerwen M, Ramos J, Liu B, Flores R, Taioli E.
    Carcinogenesis; 2019 Nov 25; 40(11):1320-1331. PubMed ID: 31169881
    [Abstract] [Full Text] [Related]

  • 32. Establishment of novel mAb to human ERC/mesothelin useful for study and diagnosis of ERC/mesothelin-expressing cancers.
    Ishikawa K, Segawa T, Hagiwara Y, Maeda M, Abe M, Hino O.
    Pathol Int; 2009 Mar 25; 59(3):161-6. PubMed ID: 19261093
    [Abstract] [Full Text] [Related]

  • 33. [Biomarkers for prevention and early diagnosis of malignant pleural mesothelioma].
    Amati M, Tomasetti M, Scartozzi M, Mariotti L, Ciuccarelli M, Valentino M, Governa M, Santarelli L.
    G Ital Med Lav Ergon; 2007 Mar 25; 29(3 Suppl):335-8. PubMed ID: 18409713
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer.
    Schneider J, Hoffmann H, Dienemann H, Herth FJ, Meister M, Muley T.
    J Thorac Oncol; 2008 Nov 25; 3(11):1317-24. PubMed ID: 18978568
    [Abstract] [Full Text] [Related]

  • 35. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
    Alemán C, Manuel Porcel J, Ma Segura R, Alegre J, Esquerda A, Ruiz E, Bielsa S, de Sevilla TF.
    Med Clin (Barc); 2009 Oct 03; 133(12):449-53. PubMed ID: 19783262
    [Abstract] [Full Text] [Related]

  • 36. Sensitivity of urinary mesothelin in patients with malignant mesothelioma.
    Creaney J, Musk AW, Robinson BW.
    J Thorac Oncol; 2010 Sep 03; 5(9):1461-6. PubMed ID: 20815094
    [Abstract] [Full Text] [Related]

  • 37. Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.
    Ak G, Tada Y, Shimada H, Metintas S, Ito M, Hiroshima K, Tagawa M, Metintas M.
    BMC Cancer; 2017 Mar 23; 17(1):212. PubMed ID: 28335760
    [Abstract] [Full Text] [Related]

  • 38. Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
    Frey AB, Wali A, Pass H, Lonardo F.
    Histopathology; 2007 May 23; 50(6):720-6. PubMed ID: 17493236
    [Abstract] [Full Text] [Related]

  • 39. Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.
    Creaney J, Francis RJ, Dick IM, Musk AW, Robinson BW, Byrne MJ, Nowak AK.
    Clin Cancer Res; 2011 Mar 01; 17(5):1181-9. PubMed ID: 21177406
    [Abstract] [Full Text] [Related]

  • 40. Current status of screening for malignant pleural mesothelioma.
    Pass HI, Carbone M.
    Semin Thorac Cardiovasc Surg; 2009 Mar 01; 21(2):97-104. PubMed ID: 19822280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.